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GENETIC TESTING'S
"SOFT UNDERBELLY"

G

enetic testing, one tool in the armamentarium of the new molecular medicine,
promises real benefits in h u m a n i t y ' s
ongoing war against sickness and premature death. It seems likely that genetic
technologies will, as is often claimed, "revolutionize" clinical medicine. Genetic testing alone
has made it possible lor physicians to:
• Alter prenatal management
• Provide more accurate diagnoses
• Predict conditions before symptoms appear
(e.g., Huntington's disease)
• Identify predispositions to a variety of conditions (e.g., colon cancer, Alzheimer's)
• Tailor pharmaceuticals to individuals
• Treat patients in utero
These can be useful developments. Even so,
the tact that the term "revolution" is used so frequently in conjunction with them should give us
pause. Although it sometimes has more benign
connotations, "revolution" is fundamentally a
political word, one suggesting force, violence,
,\m\ power. It traditionally refers to the overthrow of a regime, government, or social order. 1
The frequent conjunction of "genetics" and
"revolution" is probably not accidental. One
might argue that genetic testing also has a shadow side, a "soft underbelly" wherein it finds itself
in alliance with broader social agents, a tool by
which those who shape society wield power.

Dr. Lysaught is an assistant
professor,
Department
of
Religious Studies,
University
of Dayton, OH. Her article is
adapted from a presentation
at CHA's 14th Annual
Invitational Tfjeology and Ethics
Colloquium, San Antonio, TX, in March 2000.
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Christian
Vision and
Bio-Utopia
BY M.THERESE
LYSAUGHT, PhD

To distinguish genetic testing's positive aspects
from its downsides, we who work in Catholic
health care must begin examining these new technologies in the light of our faith tradition. In this
article, as a first step in creating such a theological-moral critique, I identify:
• four dimensions of genetic testing that belie
its benevolent image
• Three central Christian beliefs that are useful
in assessing or challenging various assumptions
and practices associated with genetic testing
By bringing the latter to bear on the former, I
hope to provide a model for how further theological-moral critique might proceed.
THE " S O F T UNDERBELLY"

T o locate genetic testing under the rubric of
"revolution," one would need to attend to the
ways in which the practice functions as a means of
power, how it contributes to the governance of
individuals, and how it seeks to affect the social
order.
These dynamics are abundantly clear in hindsight when one views the history of genetics,
which is the history of eugenics. Contemporary
practices of genetics cannot be understood without attention to the eugenic history that has
shaped the discipline of molecular biology. Even
the most cursory review of the history of eugenics
reveals how it was used in the first half of the
20th century, serving as, in Joanne Finkelstein's
words, "a mode of applied sociology": a tool for
the maintenance of a specific social order. 2
Garland Allen and Kenneth and Bettylee Garver
provide a good overview of the eugenics movement as it flourished in the United States during
this period, identifying important socioeconomic
and historical factors and some of the assumptions that guided the movement.'
Eugenics is not simply a thing of the past.
HEALTH PROGRESS
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Certain of its guiding assumptions remain alive. It
is difficult to see them, however, immersed as we
are in genetic technologies. Finkclstein suggests,
moreover, that contemporary biomedicine—
including genetic t e s t i n g exercises its power in a far
more subtle and invidious
fashion than eugenics did.
Mow do the new genetic
technologies give medicine and society through medicine—
power over our lives? I would
argue that they do so in four
ways.

Genetic Technologies Redefine Health
and Disease With the molecular
revolution, medical science
ceased believing that disease is
essentially caused by an external agent—a pathogen or carc i n o g e n , for example—and
began searching for an internal
agent instead. Consequently,
as Finkclstein notes, "genetic
flaws are being redefined into
sites of medical intervention.''*
Medicine, whether it perceives
disease to be the cause of a single-gene disorder
(because they reduce immunity to certain
pathogens) or as part of the oncological pathway,
now looks to genes as the source of disease and disorder.

.•*

'"

to a pressing problem—the presenting malady.
Now, with genetic testing, the function of diagnosis and the labeling of disease states have
become more ambiguous.
A genetic definition of disease also exponentially increases the range of possible
diseases. Once the mapping
work of the Human Genome
Project is completed, the estimated 30,000 genes in the
human complement will, in
theory, become sites for disease identification.
Genetic Technologies Redefine
Normality As more genes are
identified and more locations
for disease become available,
more "ailments" may be "discovered." Once one has a site
upon which medical science
can intervene, the temptation
for medical science to do so
increases. T r a i t s t h a t were
previously considered "normal" tend to be reclassified as
suitable for treatment. That
which can be treated becomes, almost by definition, "pathological."

This relocating of the cause of disease changes
the essential meaning of disease in at least three
ways. First, one can now—in theory—have a disease but have no symptoms. Second, one can
now be identified as having a disease before one is
even born. Third, in an odd sort of way, one can
" e a r n " a disease in one's body, never suffering a
symptom oneself but always serving as the disease's potential transmitter. These are, of course,
the presuppositions behind presymptomatic
genetic testing, prenatal genetic testing, and carrier testing. Diseases are no longer episodic
events that arise, are treated, and cured. They
have become essential parts of who we arc.

In this dynamic process, moreover, normality
and abnormality are no longer defined by the
community at large, measured by the impact of
the trait on communal life. Instead, they become
defined by the biotech industry as it decides
which conditions and disabilities will be located
and remedied and which will be, if not remedied,
stigmatized. By the same token, the pressures of
genetic reductionism suggest that remedies for
"abnormalities" need no longer be messy, com
plicated, onerous social or behavioral practices.
Now that such remedies are technological-genet
ic in nature, they would seem to be far more efficient, effective, and rational. Why should a problem drinker, for example, submit himself to
Alcoholic Anonymous's extended discipline if
gene therapy will do the trick instead?

Not only can one have a disease with no symptoms, one can also be diagnosed as possessing an
as yet symptomless disease for which no treatment exists. Indeed, for most of the conditions
for which genetic testing can currently be done,
rto therapies are available. Not that this is in itself
new••; medicine has always lacked effective therapies for at least some illnesses. But it used to be
that, even if treatment for it were absent, the
diagnosis of a disease provided both the symptomatic patient and the physician with an answer

The standardization of genetic testing may
subtly change the landscape of normality in
another way. The search for innovative and efficient approaches to genetic testing has recently
led to the development not merely of multiplex
testing—testing for more than one genetic variant
through a particular assay—but of the "gene
chip." A silicon analogue to the chips that power
personal computers, the DNA chip gives biologists a way to assay potentially thousands of genes
at one time. Now one's physician might find
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"abnormalities" no one would have suspected.
And because it measures his or her variation
against the norm at an unprecedented number of
data points, the test will also reveal a huge number of other bits of i n f o r m a t i o n . Arc these
"abnormalities''1? Are they medically significant?
How is the poor patient to know ;
Genetic Technologies Diminish Individual Autonomy Once
the gene has been defined as the disease's locus,
and once a large number of disease sites have
been identified, it will be only natural for the
biotech industry t o develop medications and
treatments for them. The internal logic of genetic
technology promises an increased "medicalization" of human life. This trend threatens to seriously diminish individual freedom and autonomy.
We know, of course, that misuse of genetic
information in the realms of employment, education, or insurance is a danger. Hut Finkelstein
suggests a more subtle and ironic threat to freedom: the way genetic testing can increase the
dependence of individuals upon the medical profession/ The mere availability of tests for hundreds of genes will encourage in increased medical surveillance of the individual body. As moretests become available and DNA chip technology
is perfected, medical specialists will have access to
AV\ infinitely greater range of information. T o test
for one condition will be to test for them all.
What would informed consent for such testing
mean in this situation? As the human genome is
mapped, more diseases are discovered, and more
treatments for these diseases are developed, individual lives themselves become increasingly
mapped by medicine. The logic that drives genetic technology seeks to bring more and more of
human life—in all its aspects, nonmedical as well
as medical—into medicine's domain.
Will patients want such tests? Some clearly will.
Some will desire information relevant t o their
immediate medical concerns. Others may be
tempted with the promise of self-knowledge. But
even if genetic tests are administered in response
to patient desires, Finkelstein, tor one, questions
the nature of the apparent autonomy involved.
For, she notes, in a technologically mediated
society, interests, values, and desires are often
cultivated by those who control the technology.
More often than not, those who control the technology are motivated by a desire for profit."
As we have seen repeatedly, especially over the
past live years or so, biotechnological research is
often initially justified by therapeutic rhetoric
(children with diseases often figure prominently
in such appeals). Cloning, it was argued, would
provide a much-needed resource for the production of scarce genetically engineered proteins.
56
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Gene "therapy," it was argued, would provide
much-needed cures for tragic single-gene disorders that caused significant childhood suffering
and early death. Sperm separation and selection
technology was developed to prevent X-linked
genetic diseases. Once researchers achieve the
necessary technological breakthroughs, however,
the focus of application tends t o change. N o
longer are the technologies restricted to a therapeutic context; often, in fact, their therapeutic
aspirations remain unrealized. Instead, the technologies are made available (at least in theory) for
any application desired by the market. Thus
researchers in New York announced last fall a
possible gene " t h e r a p y " for b a l d n e s s , and
Microsort is made available to couples who simplv wish to select the gender of their children.
Once technologies are available, applications
must be found—and it is the job of the biotech
company to cultivate in the general public a desire
for whatever outcomes such technologies can
achieve. Over time, as with ultrasound anil amniocentesis, certain technological interventions
become standard components in medical c a r e even if they provide no significant medical benefit.
In this way, individuals may find themselves
coopted into submitting to technology that does
not necessarily serve their interests. The practice of
prenatal genetic testing is a case in point. As two
students of the procedure have observed, "The
majority of current genetic testing is geared to
counseling for reproductive or prenatal decisions.""
Note that prenatal diagnosis is not conducted to
design therapies for the fetus, the child-to-be. As
for prenatal counseling, couples who choose to be
tested may in tact find themselves in a traumatic sit
uation—as when, for example, they learn that the
fetus has certain anomalies and they must decide
what to do about it. Such "freedom" has large
implications. The termination of one genetically
defective fetus does not a eugenics movement
make, but each act, when multiplied by thousands
or millions, translates into a significant social
impact. As for client autonomy, are not the decisions in such cases at least partly shaped by the
practitioner who does the testing?

Genetic Technologies Promote a Vision of Utopia Behind
genetic testing is a vision—a vision, as Finkelstein
calls it, of "bio-utopia." 8 Each new development
and discovery promises an end to disease as we
know it (listen, for example, to the rhetoric surrounding gene therapy and human embryonic
stem cells), as well as limitless human enhancement. Genetic testing is seen as a vital first step
toward a kind of Holy Grail. Medicine, through
genetic and allied technologies, promises the perfection of human life.
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This is, of course, an eschatological vision, a
vision of what the world will be like when the savior—medicine, in this case—comes into its own.
Once one starts discussing eschatology, however,
one leaves the realm of medicine and moves into
the realm of theology.
THEOLOGICAL SOURCES OF RESISTANCE

If the genetic turn in medicine is indeed a revolution, if it entails a new exercise of power and is
grounded in a particular eschatological vision,
h o w should Catholic medical p r a c t i t i o n e r s
respond to it? Ought they simply profess loyalty
to the new regime and accept practices that consolidate the new power? Or is the question more
complex? Is resistance in order, at least to some
degree? And, if it is in order, from whence might
such resistance arise?
Catholics—and Christians generally—know
themselves to be citizens of a different regime,
namely, the church. Here, within the Christian
theological tradition, practitioners and patients
might find resources for a more nuanced and
careful appropriation of the practice of genetic
testing. Three convictions central to the Catholic
tradition provide some critical purchase on these
questions.
A Traditional Commitment to Healing Catholic thinking
about any aspect of health care ought to begin
with one of Jesus' primary activities: healing. The
Ethical and Relijjious Directives for Catholic
Health Care Services emphasizes the ccntrality of
healing for a Catholic approach to health care; its
very first sentences say, "The Church has always
sought to embody our Savior's concern for the
sick. The gospel accounts of Jesus' ministry draw
special attention to his acts of healing. . . . In
faithful imitation of Jesus Christ, the Church has
served the sick, suffering, and dying in various
ways throughout history.""
God (the tradition attests) affirms life, wellness, wholeness, and embodied
flourishing.
Medicine and its various technologies are rightly
seen as elements of God's good creation, agents
of God's healing. Those who practice the art of
medicine should see themselves as ministers of
God's grace and presence.
This commitment to healing provides us with
substantive guidance for understanding the technology of genetic testing. In cases where genetic
testing aids critical medical diagnosis and furthers
therapeutic intervention, it is clearly a legitimate
medical tool. Its use ought to be encouraged in
the following sorts of situations:
• Diagnosing a presenting illness to determine
the proper course of treatment for it
• Presymptomatic testing for illnesses (e.g.,
HEALTH PROGRESS
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colon cancer) in which early detection could be
beneficial and effective treatment is available
• Carrier testing in counseling a couple at risk
for transmitting a serious congenital illness (e.g.,
Tay-Sachs disease) accompanied by significant
suffering and early mortality
Genetic testing in such situations furthers the
end of healing. In others, however, its healing
dimension is more dubious. One can clearly wonder whether the tools of medicine should be used
for nonmedical purposes—employment testing,
for example. What about tests designed to diagnose conditions for which no effective therapy
exists? Of what medical use is it (aside from
deciding whether to have children) to learn that
one will someday be stricken with Huntington's
or Alzheimer's? How could such knowledge be
described as "healing"?
The Christian commitment to healing should
also inspire questions concerning testing practices
that simply increase the medicalization of human
life. Such practices include:
• Testing for conditions for which patients are
not at risk and for which no symptoms are presenting, especially multiplex testing
• Testing for a condition that does not significantly affect the patient's physical well-being but
tor which a putative treatment exists
Medicalization—which enlarges disease's role
in the life of the person—is antithetical to a vision
of healing. It is also antithetical to the Christian
commitment to responsible stewardship of health
care r e s o u r c e s . In the Christian t r a d i t i o n ,
medicine is not a consumer commodity supplied
to patients simply because they desire its power.
Medicine is (or ought to be) a tool of healing, a
service to the sick, suffering, and dying.
The Image of a Trinitarian God As Rev. Benedict
Ashley, O P , and Rev. Kevin O'Rourke, OP, have
said so well, "The basic principle of healthcare
ethics is the dignity of the human person. . . .
The goal of healthcare is to contribute to the full
development of human persons. . . . Healthcare
tails whenever it tends to depersonalize its clients
by ignoring or restricting this freedom."1" Such a
claim may seem on the surface rather formal, but
Ashley and O'Rourke make it clear that the terms
"dignity" and "full development," as they use
them, are informed by a specific tradition rich
with meaning.
A theological understanding of the dignity of
the human person begins with a general recognition of the goodness of God's creation. We, along
with all other living things, were called into being
by God and are sustained by G o d ' s gracious
goodness. As such, we are to be celebrated, nourished, and helped to flourish to the fullest extent
MARCH - APRIL 2 0 0 1 •
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possible. What is more, the tradition affirms from
the beginning that humans have the added grace
of being created in the image and likeness of
God." This is a rich metaphor, thick with multiple
meanings (creator, servant, sufferer, redeemer),
pointing us tow aid that which we are called to be.
The fact that humans are created in the image
of God points to the essence of God's nature,
captured in the mystery of the Trinity. The Trinity
is certainly a complex metaphor (not to mention a
mystery), but also one that has been richly
explored in the tradition. In the early church,
Augustine's De Trinitate was the most influential
explanation of t h e d o c t r i n e of t h e Trinity.
Augustine, who interpreted the Trinity through
the theological claim that God is love, described it
as the dynamic interchange that exists between a
lover, the beloved, and the love they share.
This image points to one fundamental significance of the doctrine of the Trinity, namely, the revelation that God's nature, the Very essence of God is
relational. God is not monolithic. God's essential
reality is a community of persons, who, as love, live
in perpetual self-giving and self-receiving.13 A constitutive member of the Trinity is, moreover, the Son,
the subject not only of the Incarnation and
Resurrection but also of the Passion. The Son suffered. The experience of suffering is intrinsic to the
very identity and being of the Trinity.
How might such a vision of the Trinity speak
to genetic testing as a technology practiced upon
persons created in a Trinitarian image and like
ness? It would celebrate genetic testing insofar as
it contributes to human flourishing, especially by
preventing disease and promoting healing. In
tact, the vision would remind practitioners that
people flourish most fully when they are liberated
from medical care—when they are well. By the
same token, the vision would critique those
genetic testing practices that decrease human
freedom by increasing dependence on medicine.
(When, for example, genetic testing confuses disease with identity, or multiplies interventions for
trivial conditions, or increases medical surveillance of the body, it puts human beings into a
kind of bondage to medicine.) And the vision of
the Trinity would critique genetic testing that, on
one hand, manipulates patients' desires in the
interest of profit or social control, while, on the
other hand* it promotes the myth that those
patients are making autonomous choices.
But threats to freedom are not the only ways in
which genetic testing may undercut human dignity .md flourishing. Eugenic applications of prenatal genetic testing directly deny the goodness of
God's creation and contribute in no way to the
development of persons. Persons flourish most
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fully, the trinitarian tradition affirms, as their connectedness in community and their network of
relationships increases. That being the case, uses
of genetic tests that handicap persons socially by
stigmatizing them as intrinsically "abnormal" will
obstruct their full development. Finally, the tradition affirms that suffering, t h o u g h not to be
sought out, is both a part of the human condition
and theologically charged. As the Ethical ana"
Relijjious Directives note:
For the Ghristian, our encounter with suffering and death can take on a positive and
distinctive meaning through the redemptive power of Jesus' suffering and death. As
St. Paul says, we are "always carrying about
in the body the dying of Jesus, so that the
life of Jesus may also be manifested in our
body" (2 Cor 4:10). This truth does not
lessen the pain and fear, but gives confidence and grace for bearing suffering rather

than being overwhelmed by it. Catholic
health care ministry bears witness to the
truth that, for those who are in Christ, suffering and death are the pangs of a new creation. " G o d himself will always be with
them . . . » "
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An Alternative Eschatology This refusal to shy away
from the reality of suffering and abandon those
who suffer from genetic conditions brings us to
our last point. Genetic technologies, as noted
above, presume an eschatological vision. A different eschatological vision underpins the whole of
the Christian tradition. The Catholic author
Flannery O'Connor captures this vision in her
characteristically startling fashion in her short
story "Revelation," a story that, interestingly
enough, begins in a physician's office. Near the
end of the story, the major character, Mrs.
Tuipin, experiences a vision:
There was only a purple streak in the sky,
cutting through a field of crimson and leading, like an extension of the highway, into
the descending dusk. She raised her hands
from the side of the [pig] pen in a gesture
hieratic and profound. A visionary light settled in her eyes. She saw the streak as a vast
swinging bridge extending upward from
the earth through a field of living fire.
Upon it a vast horde of souls were rumbling toward heaven. There were whole
companies of white-trash, clean for the first
time in their lives, ^nd bands of black[s] in
white robes . . . and battalions of freaks and
lunatics. . . . And bringing up the end of
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the procession was a tribe of people whom
she recognized at once as those who, like
herself and Claud, had always had a little of
everything and the God-given wit to use it
right. She leaned forward to observe them
closer. They were marching behind the
others with great dignity, accountable as
they had always been for good order and
common sense and respectable behavior.
They alone were on key. Yet she could see
by their shocked and altered faces that even
their virtues were being burned away."
O'Connor, herself a victim of the debilitating
disease lupus, is here echoing the biblical vision of
the Eucharistic i\iu\ eschatological banquet found,
among other places, in the Gospel of Luke.1" (This
banquet is also invoked in the conclusion of the
Ethical ami Religions Directives.) Note the difference between Christian eschatology and secular
eschatology. Unlike the secular vision, the
Christian vision includes impaired people in its
number: freaks, lunatics, the maimed, the blind,
and the lame. In tact, as O'Connor shows, in the
Christian vision these figures become central. In
the Gospel, those who are healthy, prosperous,
and socially successful—by all standards "perfect"—
refuse to come to the banquet. They exclude
themselves. O'Connor's vision adds ^\n interesting
twist: Here the healthy and socially secure are in
the procession, but their perfections—"even their
virtues," as she puts it—are being "burned away."
O'Connor's immersion in the Catholic tradition
informs her understanding that our pretensions to
perfection, especially our "natural" virtues, are, in
eschatological terms, vices.
A practice of genetic testing that promotes
healing and the dignity of the human person
should be celebrated as a ministry of discipleship
and a creation of God's goodness. Insofar as such
a practice sees itself as promoting a secular eschatology, however, it will find itself at odds with the
meaning and purpose of Catholic health care.
Practitioners and patients grounded in Christian
eschatology will remember that the agent of
human perfection is God, not genetics, and will
recognize the genetically impaired as the privileged guests at the banquet. The Christian eschatological vision is a political vision—a vision of the
Kingdom. We, confronted by the genetic revolution, must decide which of the two regimes will
have dominion over our lives.
o
/ would like to thank Ron Hamel ami the planning committee of C'HA's 14th Annual Invitational Theology and
Ethics Colloquium for providing me with the opportunity
to prepare these remarks.
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15. "When one of those who sat at table with him heard
this, he said to him, 'Blessed is he who shall eat
bread in the Kingdom of God!' But he said to him, 'A
man once gave a great banquet, and invited many;
and at the time for the banquet he sent his servant to
say to those who had been invited, 'Come; for all is
now ready.' But they all alike began to make excuses.
The first said to him, 'I have bought a field, and I must
go out and see it; I pray you, have me excused.' And
another said, 'I have bought five yoke of oxen, and I
go to examine them; I pray you, have me excused.'
And another said. 'I have married a wife, and therefore I cannot come.' So the servant came and reported this to his master. Then the householder in anger
said to his servant, 'Go out quickly to the streets and
lanes of this city, and bring in the poor and maimed
and blind and lame.' And the servant said, 'Sir. what
you commanded has been done, and still there is
room.' And the master said to the servant, 'Go out to
the highways and hedges, and compel people to
come in, that my house may be filled. For I tell you,
none of those men who were invited shall taste my
banquet" (Lk 14:15-24).
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